Amlodipine Besylate Tablet
Product Images NDC 71610-539
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Amlodipine Besylate (NDC 71610-539). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 01 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 02)
Figure 02 (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 03)
This is a tabular representation of a clinical study with 1318 patients, divided into age groups (<65 and >=65) and gender (male and female) along with their baseline Sitting SBP and Vessel Disease. The study also takes into account the number of patients with stenosis (At least one Vessel with > 60% Stenosis and Ho Vessel with > 60% Stenosis). Furthermore, it segregates patients based on the PCl-stent strata (No PCI, POl Without Stent Placement, and Stent Placement) and compares the result of Amlodipine and Placebo. The description of the study's outcomes is not available.*
Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 04)
Logo (14b2acb6 Ce0c 4f70 9d0a B6726c945ac2 05)
Bottle Label 5 mg (71610 0539 60)
Aphena Pharma Solutions (TN)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.